|
PFN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.74050004700888E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.10150005467369E-09 |
| Normal-vs-Stage2 |
1.92035999999618E-05 |
| Normal-vs-Stage3 |
1.76202999999653E-05 |
| Normal-vs-Stage4 |
2.626000E-01 |
| Stage1-vs-Stage2 |
9.552800E-01 |
| Stage1-vs-Stage3 |
9.532800E-01 |
| Stage1-vs-Stage4 |
1.912610E-01 |
| Stage2-vs-Stage3 |
9.186400E-01 |
| Stage2-vs-Stage4 |
3.566800E-01 |
| Stage3-vs-Stage4 |
3.801600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.07209999053748E-09 |
| Normal-vs-AfricanAmerican |
6.19789999999343E-05 |
| Normal-vs-Asian |
4.778700E-03 |
| Caucasian-vs-AfricanAmerican |
5.701000E-01 |
| Caucasian-vs-Asian |
8.587200E-01 |
| AfricanAmerican-vs-Asian |
9.525800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77279985031009E-10 |
| Normal-vs-Female |
1.003710E-03 |
| Male-vs-Female |
8.156200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.724000E-03 |
| Normal-vs-Extreme_Weight |
4.01410005235192E-09 |
| Normal-vs-Obese |
2.77949999683003E-08 |
| Normal-vs-Extreme_Obese |
2.643600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.248200E-02 |
| Normal_Weight-vs-Obese |
1.218350E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.366600E-01 |
| Extreme_Weight-vs-Obese |
8.122800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.762600E-01 |
| Obese-vs-Extreme_Obese |
5.157400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.101800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.52800000430275E-08 |
| Normal-vs-Age(61-80Yrs) |
5.09950000004977E-08 |
| Normal-vs-Age(81-100Yrs) |
2.24859999997662E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.850800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.382800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.893030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.987600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.656000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.751600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.03237426887881E-12 |
| Normal-VS-Type2 PRCC |
2.15969999994847E-06 |
| Normal-VS-KIRP CIMP |
1.396630E-01 |
| Normal-VS-Unclassified PRCC |
1.92589999947756E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.362000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.15300000050433E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
6.016800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.342980E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.827600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.70400000004878E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.92415005939984E-13 |
| Normal-vs-N1 |
1.013800E-02 |
| Normal-vs-N2 |
3.649200E-01 |
| N0-vs-N1 |
2.701700E-03 |
| N0-vs-N2 |
6.754200E-01 |
| N1-vs-N2 |
5.901600E-01 |
|
|
